Chi Yan, Weifeng Luo, Jinming Yang, Jing Yang, Sheau-Chiann Chen, Kensey Bergdorf, Qianni Hu, Vivian L. Weiss, Douglas B. Johnson, Qi Liu, Ann Richmond. "RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b+ Bregs thereby overcoming melanoma PD1-resistance." Nature Communications, 2026. doi:10.1038/s41467-025-67315-1